|
|
Volumn 30, Issue 2, 2012, Pages 121-123
|
|
Sangamo's lead zinc-finger therapy flops in diabetic neuropathy.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
VASCULOTROPIN A;
VEGFA PROTEIN, HUMAN;
ZINC FINGER PROTEIN;
DIABETIC NEUROPATHY;
DRUG APPROVAL;
ECONOMICS;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INDUSTRY;
NOTE;
PHASE 2 CLINICAL TRIAL (TOPIC);
UNITED STATES;
CLINICAL TRIALS, PHASE II AS TOPIC;
DIABETIC NEUROPATHIES;
DRUG APPROVAL;
HUMANS;
INDUSTRY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
ZINC FINGERS;
|
|
EID: 84864513068
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0212-121a Document Type: Note |
|
Times cited : (16)
|
|
References (0)
|
